We received an allegation of questionable inr results for one patient tested on a coaguchek xs meter compared to an unknown laboratory methodology.On (b)(6) 2022, at 11:00 a.M., the laboratory result was 2.41 inr.On (b)(6) 2022, at 12:20 a.M., the patient's inr result on the coaguchek xs meter was 1.7 inr.The patient's therapeutic range was requested but not provided.The serial number of the coaguchek xs meter was requested but was not provided.
|
The customer material was requested for investigation.The product has not been received at this time.If the product is returned in the future, a follow-up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and the results have passed the internal inspection.Product labeling states: "the coaguchek system uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas deviations can occur when compared to methods using other thromboplastins.However, those deviations between thromboplastins of different origins (e.G., rabbit based) are not specific to coaguchek products.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared to other laboratory methods.".Reporter: occupation is patient/consumer.
|